NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025
Buyer: NHS England
- Published
- 6 October 2025
- Estimated value
- £1,471,752,146
- Procedure
- Open procedure
- Lots
- 1
- Notice number
- 062482-2025
- Reference
- ocds-h6vhtk-055064
- Official source
- Official source
CPV codes
- 33600000Pharmaceutical products
Description
NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025 Offer reference number: CM/PHS/25/5728 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months. Potential periods of call-offs under the framework agreement: CM/PHS/25/5728/01 - National Framework for Medical Retinal Vascular Treatments: 7NAT (National) 01/12/2025 to 31/05/2027 (18 months) CM/PHS/25/5728/02 - Regional Framework for Medical Retinal Vascular Treatments aflibercept 2mg: NOFE: (North of England) 01/12/2025 to 31/05/2027 (18 months) SOFE: (South of England) 01/12/2025 to 31/05/2027 (18 months) MAE: (Midlands and East) 01/12/2025 to 31/05/2027 (18 months) LNW: (London) 01/12/2025 to 31/05/2027 (18 months) Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England Provision of Licensed Medical Retinal Vascular Anti Veg-F and Intravitreal Corticosteroid medicines used in medical retinal vascular services for the NHS in England. To include but not limited to aflibercept, bevacizumab, brolucizumab, intravitreal dexamethasone, intravitreal fluocinolone, farici…
Awards
| Awarded to | Amount | Date |
|---|---|---|
| Abbvie Ltd | — | — |
| Alimera Sciences | — | — |
| BAYER PUBLIC LIMITED COMPANY | — | — |
| BIOGEN IDEC LIMITED | — | — |
| NOVARTIS PHARMACEUTICALS UK LIMITED | — | — |
| Orion Pharma (UK) Ltd | — | — |
| Outlook Therapeutics, Inc. | — | — |
| Roche Products Ltd | — | — |
| Teva UK Limited | — | — |
| Thornton and Ross Ltd | — | — |
Official publications
- FTS · 062482-2025 · 6 October 2025
Other tenders from NHS England
- RFI - National Asset Survey Programme
- NHS National Framework for Tafamidis
- Maternity and Neonatal Patient Reported Experience Measure (MatNeo PREM)
- Co-producing & evaluating interventions to support MMRV uptake Somali community
- NHS Chief Executive Readiness Assessment Model
- NHS Talking Therapies for Anxiety and Depression - RFI
- Chairs extended offer
- Soft Skills Course for GP IMGs (2026-2031)
- National Gambling Helpline
- Leadership Development to Support Engagement and Learning for Harmed Families
Frequently asked questions
- What is the estimated value of this tender?
- The estimated value published by the buyer is £1,471,752,146.
- Who is the buyer of this tender?
- The contracting authority is NHS England (United Kingdom).
- How can I bid for public tenders in the United Kingdom?
- Bids are submitted through the official public procurement portal in the United Kingdom. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Create a free account and receive new public tenders published in the United Kingdom that match your business, every day.